Clinical Trials Logo

Filter by:
NCT ID: NCT06059456 Completed - Clinical trials for Influenza Immunization (Healthy Volunteers)

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Start date: October 2, 2023
Phase:
Study type: Observational

This EPSS will determine the vaccinee reporting rates (RRs) of suspected ADRs following routine vaccination with VaxigripTetra® and Efluelda® respectively, during the NH influenza season 2023/24. The primary objective of this surveillance is to estimate the vaccinee reporting rate (RR) of suspected adverse drug reactions (ADRs) occurring within 7 days following routine vaccination with VaxigripTetra® and Efluelda® respectively, during the Northern Hemisphere (NH) influenza season 2023/24. Study duration per participant 2 months (including 6 weeks for VC distribution 2 weeks for vaccinee reporting) following the first vaccination

NCT ID: NCT06054958 Completed - Clinical trials for Postural Orthostatic Tachycardia Syndrome

POTS-CFS Study: Orthostatic Intolerance in the Context of Pediatric ME/CFS

POTS-CFS
Start date: December 6, 2021
Phase:
Study type: Observational

Pilot-case-control study on exertion and orthostatic intolerance of adolescents with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) compared to age-matched healthy controls (HC).

NCT ID: NCT06054048 Completed - Cancer Clinical Trials

Open Video System in Medicine (oVID)

oVID
Start date: February 1, 2019
Phase: N/A
Study type: Interventional

Currently, there are no telemedical visits between patients and/or their relatives and a palliative physician for the evaluation of symptom and progress monitoring. This is done during visits of the patient by the coordinators and palliative physicians of the palliative network/PKD Münster (PKD = Palliative Care Consultation Service) and/or the general practitioners. Upon enrollment in the Palliative Network/PKD Münster, patients receive a 24-hour emergency telephone number. This is staffed by a caregiver who coordinates the deployment of other caregivers / palliative care physicians according to the information provided by the patient / family members. If patients are randomized to the "telemedicine" group, they have the option of using ELVI (ELVI = electronic visit) in addition to conventional care, and thus the possibility of televisits with physicians or nurses. In this case, they receive access data for ELVI, i.e., an access code for a virtual waiting room. In addition, patients will be given questionnaires at discharge to be completed on the day of discharge and on days 7, and 14. The primary objective of this randomized trial is to demonstrate that telemedically managed patients are not relevantly inferior to conventionally managed patients in terms of change in Integrated Palliative care Outcome Scale (IPOS) from the day of discharge (non-inferiority question), although the possibility of televisiting may result in less frequent physician visits to the patient's home.

NCT ID: NCT06048536 Completed - Contraception Clinical Trials

Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

Start date: December 22, 2023
Phase: Phase 2
Study type: Interventional

A single-center, randomized, open-label, parallel-group, multi-arm, phase II clinical trial in healthy women aged 18 to 35 years who have a documented ovulatory cycle prior to randomization.

NCT ID: NCT06045442 Completed - Clinical trials for Chronic Kidney Diseases

Dialysis Exercise With a Bed Compatible Leg TRAiningstool

DEXTRA
Start date: May 3, 2023
Phase: N/A
Study type: Interventional

This study is a randomised controlled intervention trial for dialysis patients with chronic kidney disease (n=32). The aim of this study is to test the effectiveness of an intradialytic training with a simple bed compatible trainingstool in comparison to a control group.

NCT ID: NCT06042192 Completed - Healthy Clinical Trials

Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.

Start date: September 14, 2023
Phase: Phase 1
Study type: Interventional

This study is a multi center, multiple dose, open label trial to evaluate the adhesion of TK-254RX in healthy volunteers. The primary purpose of this study is to evaluate the adhesion of TK-254RX. Secondary purpose is to show TK-254RX is safe and to explore and compare adhesion assessment methods.

NCT ID: NCT06041438 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

Start date: September 29, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the effect on the exposure of BI 1584862 in plasma when given as single dose together with multiple doses of itraconazole (Test, T) as compared to BI 1584862 when given alone as oral single dose (Reference, R).

NCT ID: NCT06040723 Completed - Clinical trials for Gastroesophageal Hernia

Hill-grade Knowledge Via Integrated Neural-network for Gastroscopy

HillKING
Start date: October 10, 2023
Phase:
Study type: Observational

The Hill classification, also known as the Hill grade, is a system used to classify the severity of gastroesophageal valve incompetence, specifically related to gastroesophageal reflux disease (GERD) and hiatal hernia. This study aims to compare the ability of physicians versus an AI model to asses the Hill grade during gastroscopy.

NCT ID: NCT06040307 Completed - Pain, Postoperative Clinical Trials

Guiding Opioid Administration in Patients With Regional Anesthesia

GORA
Start date: December 18, 2023
Phase: N/A
Study type: Interventional

General anesthesia is a combination of hypnotic drugs to achieve unconsciousness and opioid analgesics to ensure antinociception. An alternative approach to the intraoperative administration of high potency opioids in order to achieve antinociception during surgery is combining a general anesthesia with a regional anesthesia. Modern general anesthesia aims to treat nociception induced by surgical stimulation while avoiding an overdose of opioid analgesics and reducing side-effects of opioid administration. Quality and safety of general anesthesia are of major clinical importance and can be improved by adjusting the opioid analgesics to the optimal individual dose needed. In the current clinical practice, the opioid dosage is usually chosen by clinical judgment. Recently different monitoring devices estimating the effect of nociception during unconsciousness have become commercially available. One of the first commercially available nociception indices was the Surgical Pleth Index (SPI) derived by the CARESCAPEā„¢B650 patient monitor (GE Healthcare). Until today, it remains unknown whether guiding sufentanil administration by SPI monitoring affects the administered amount of intraoperative and postoperative opioid, immediate postoperative pain in the postanesthesia care unit (PACU) and the quality of postoperative recovery in patients with a combination of general and regional anesthesia. This study aims to investigate whether guiding sufentanil administration by SPI monitoring - compared to routine care - reduces intraoperative sufentanil consumption in patients having trauma and orthopaedic surgery with a combination of general and regional anesthesia.

NCT ID: NCT06037538 Completed - Diabetes Clinical Trials

User Evaluation of BGM JS200B

Start date: April 19, 2023
Phase: N/A
Study type: Interventional

Performance Evaluation by the User of the Blood Glucose Monitoring System JS200B in accordance with DIN EN ISO 15197:2015